These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14614948)

  • 1. Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex.
    Ago Y; Koyama Y; Baba A; Matsuda T
    Neuropharmacology; 2003 Dec; 45(8):1050-6. PubMed ID: 14614948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice.
    Ago Y; Sakaue M; Baba A; Matsuda T
    J Neurochem; 2002 Oct; 83(2):353-9. PubMed ID: 12423245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.
    Herian M; Wojtas A; Sobocińska MK; Skawski M; González-Marín A; Gołembiowska K
    Pharmacol Rep; 2020 Dec; 72(6):1593-1603. PubMed ID: 33174181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Sakaue M; Somboonthum P; Nishihara B; Koyama Y; Hashimoto H; Baba A; Matsuda T
    Br J Pharmacol; 2000 Mar; 129(5):1028-34. PubMed ID: 10696105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT
    Hagino Y; Hall FS; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacol Rep; 2021 Mar; 41(1):91-101. PubMed ID: 33547882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
    Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex.
    Regina MJ; Winter JC; Rabin RA
    Neuropharmacology; 2003 Dec; 45(8):1041-9. PubMed ID: 14614947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.
    Winstanley CA; Theobald DE; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2005 Apr; 30(4):669-82. PubMed ID: 15688093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MKC-242, a novel 5-HT1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats.
    Somboonthum P; Matsuda T; Asano S; Sakaue M; Baba A
    Neuropharmacology; 1997; 36(11-12):1733-9. PubMed ID: 9517445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
    Lorrain DS; Matuszewich L; Hull EM
    Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of 5-HT1A and σ1 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency.
    Hiramatsu N; Ago Y; Hasebe S; Nishimura A; Mori K; Takuma K; Matsuda T
    Neuropharmacology; 2013 Dec; 75():53-61. PubMed ID: 23851260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonist in mice.
    Nakamura S; Ago Y; Hayashi A; Itoh S; Kakuda M; Hashimoto H; Baba A; Matsuda T
    Synapse; 2006 Dec; 60(7):479-84. PubMed ID: 16952156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.